1. Zhou Y, Hou Y, Shen J, et al. Network-based drug repurposing for novelcoronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery. 2020;6(1):14. doi.org/10.1038/s41421-020-0153-3
2. Muxel SM, Pires-Lapa MA, Monteiro AWA, et al. NF-κB drives thesynthesis of melatonin in RAW 264.7 macrophages by inducingthe transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. PLoS One. 2012;7(12):e52010. doi.org/10.1371/journal.pone.0052010
3. Reiter RJ, Sharma R, Ma Q, et al. Inhibition of mitochondrial pyruvatedehydrogenase kinase: a proposed mechanism by which melatonincauses cancer cells to overcome cytosolic glycolysis, reduce tumorbiomass and reverse insensitivity to chemotherapy. Melatonin Res.2019;2(3):105-119. doi.org/10.32794/mr11250033
4. Acuña-Castroviejo D, Noguiera-Navarro MT, Reiter RJ, et al. Melatoninactions in the heart; more than a hormone. Melatonin Res. 2018;1(1):21-26.doi.org/10.32794/mr11250002
5. Biancatelli RMLC, Berrill M, Mohammed YH, et al. Melatonin forthe treatment of sepsis: The scientific rationale. J Thoracic Disease.2020;12(1):54-65. doi.org/10.21037/jtd.2019.12.85
6. Boga JA, Coto-Montes A, Rosales-Corral SA, et al. Beneficial actionsof melatonin in the management of viral infections: a new use for this“molecular handyman”? Rev Med Virology. 2012;22(5):323-338. doi.org/10.1002/rmv.1714
7. Reiter RJ, Ma Q, Sharma R. Treatment of ebola and other infectiousdiseases: melatonin “goes viral.” Melatonin Res. 2020;3(1):43-57. doi.org/10.32794/mr11250047
8. Hsing AW, Meyer TE, Niwa S, et al. Measuring serum melatonin inepidemiologic studies. Cancer Epidemiology Biomarkers Prevention.2010;19(4):932-937. doi.org/10.1158/1055-9965.EPI-10-0004
9. Dinicolantonio JJ, McCarty M, Barroso-Aranda J. Melatonin maydecrease risk for and aid treatment of COVID-19 and other RNAviral infections. Open Heart. 2021;8(1):e001568. doi.org/10.1136/openhrt-2020-001568
10. García IG, Rodriguez-Rubio M, Mariblanca AR, et al. A randomizedmulticenter clinical trial to evaluate the efficacy of melatonin in theprophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVIDTrial): a structured summary of a study protocol for a randomisedcontrolled trial. Trials. 2020;21:1-4. doi.org/10.1186/s13063-020-04436-6
11. Ameri A, Asadi MF, Kamali M, et al. Evaluation of the effect ofmelatonin in patients with COVID-19-induced pneumonia admittedto the intensive care unit: a structured summary of a study protocolfor a randomized controlled trial. Trials. 2021;22:1-2. doi.org/10.1186/s13063-021-05162-3
12. Anderson G, Reiter RJ. Melatonin: roles in influenza, COVID-19,and other viral infections. Rev Med Virology. 2020;30(3):e2109. doi.org/10.1002/rmv.2109